XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Consolidated Revenues Attributable to Products or Services (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 100.00% 100.00% 100.00% 100.00%
Pharma Services [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 94.00% 11.00% 62.00% 18.00%
DetermaRx [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 6.00% 0.00% 3.00% 0.00%
Discontinued Operations [Member]        
Disaggregation of Revenue [Line Items]        
Concentration risk, percentage 0.00% 89.00% 35.00% 82.00%